SITC Advances in Cancer Immunotherapy (ACI) for Radiation Oncologists
There is considerable research in preclinical and clinical domains that has investigated therapeutic interactions between radiation therapy and immunotherapies and these treatment modalities are increasingly being used in conjunction with each other.
Category
  • General RO
  • Immunotherapy
Format
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $229.00
Physics I-IV and Principles of Clinical Molecular Imaging (from the RPT Curriculum Supplement Series)
Topics Covered:Principles of Clinical Molecular Imaging for Radiopharmaceutical Therapy—Vikas Prasad, MD, PhD
Category
  • Physics
  • Radiobiology
  • Radiopharmaceutical Therapy
Format
  • onDemand
  • Webinars
Credits
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Certificate of Attendance
Cost $379.00
Introduction, Radiobiology I-II, Chemistry, and Dosimetry I-II (from the RPT Curriculum Supplement Series)
Topics Covered:Introduction to Radiopharmaceutical Therapy and Curriculum Overview—Ana Kiess, MD, PhD
Category
  • Physics
  • Radiobiology
  • Radiopharmaceutical Therapy
Format
  • onDemand
  • Webinars
Credits
  • 4.00 AMA PRA Category 1 Credit™
  • 4.00 Certificate of Attendance
Cost $379.00
Miscellaneous & Future Applications / Authorized User (from the RPT Curriculum Supplement Series)
Topics Covered:Miscellaneous and Future Applications of Radiopharmaceutical Therapy – How To Become an Authorized User, Meta-iodobenzylguanidine, Rhenium Skin Cancer Therapy, Radiosynoviorthesis, Alpha Emitters, Other
Category
  • Physics
  • Radiobiology
  • Radiopharmaceutical Therapy
Format
  • onDemand
  • Webinars
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Quality and Safety (from the RPT Curriculum Supplement Series)
Topics Covered:Principles of Patient-Centered Clinical Radiopharmaceutical Therapy: Quality and Safety —Hyun Kim, MDFor the presentation description, please see the Program tab.
Category
  • Patient Safety
  • Physics
  • Radiobiology
  • Radiopharmaceutical Therapy
Format
  • onDemand
  • Webinars
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Therapy-Specific Considerations I-III (from the RPT Curriculum Supplement Series)
Topics Covered:Therapy-Specific Considerations I - Therapy-Specific Considerations for Lu-PSMA-617—Jeff M. Michalski, MD, MBA, FASTRO
Category
  • Physics
  • Radiobiology
  • Radiopharmaceutical Therapy
Format
  • onDemand
  • Webinars
Credits
  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 Certificate of Attendance
Cost $449.00
Oligometastatic Prostate Cancer: How Far Do We Go?
There have been many advancements in terms of treatment and imaging modalities for patients with oligometastatic prostate cancer. Failure to understand these advancements in treatment options leads to lower quality of care delivered by clinicians treating prostate cancer patients.
Category
  • Genitourinary
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Challenging Cases in the Management of Squamous Cell Carcinoma of the Skin
There is a general understanding and comfort in management of small, relatively well-defined SCC of the skin, even those that carry some high risk features (PNI, high DOI, high grade, etc).
Category
  • Head and Neck
  • Sarcoma
Format
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Clinical Applications of AI: Contouring and Patient-Specific QA
There are many advances in the application of artificial intelligence (AI) in contouring and segmentation, as well as patient specific quality assurance.
Category
  • Patient Safety
  • Physics
Format
  • Sessions onDemand
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Certificate of Attendance
  • 0.75 SA-CME
Cost $149.00
Stereotactic Radiotherapy and Renal Cell Cancer: Overcoming Radioresistance and the Resistance to Radiate
The use of SABR is well established in many cancers, however, its application within kidney cancer is relatively new. This is largely due to the historical notion that renal cell carcinoma (RCC) is highly radioresistant.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00

Pages